Target intelligence / Profile preview

Natural Killer Cell Receptor NKp44 (NKp44)

Target
NKp44
Molecular classification
Receptor, Transmembrane glycoprotein, Natural Cytotoxicity Receptor (NCR)
01

Overview

NKp44 (NCR2, CD336) is an activating receptor expressed on activated natural killer (NK) cells and some innate lymphoid cell subsets. It belongs to the natural cytotoxicity receptor (NCR) family and plays a critical role in recognizing and eliminating virus-infected and tumor cells. Upon ligand binding, NKp44 signals through the DAP12 adaptor protein to trigger NK cell effector functions. The receptor interacts with both activating and inhibitory ligands, such as PCNA, which can modulate its activity.

Other names
NCR2CD336
02

Mechanism of action

Activation of NK cells leading to degranulation and cytokine production.

03

Biological functions

Immune responseCytotoxicityNK cell activationSignal transductionTissue homeostasisImmune regulation
04

Disease associations

CancerViral infectionAutoimmunity
05

Safety considerations

Potential for off-target effects due to expression on certain ILC subsets.Possible immune-related adverse events due to NK cell activation.

Beyond the preview

Go deeper on Natural Killer Cell Receptor NKp44 (NKp44).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural Killer Cell Receptor NKp44 (NKp44).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call